Research·October 19, 2026 at 1:03 PM EDT·1 source
#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and more
ZLAB +9.0%GSKMRK
ZLAB · last 30 trading days-0.1% since the news
News
What happened
- ESMO26 regular abstracts will feature Zai Lab, GSK, Merck and other companies.
- The article highlights anticipated first-line bladder-cancer data as a potential congress focus.
Why it matters
The abstracts may provide early signals on oncology clinical data and competitive positioning for healthcare investors and professionals monitoring drug development.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Who is involved
#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and moreZai LabZLABGSKGSKMerckMRK
Company
Sources (1)
- Endpoints NewsOct 19#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and more
Related
- Oct 21 · Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Yesterday · STAT+: The ESMO presentation everyone’s been waiting for
- Yesterday · Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- Oct 23 · Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
- Oct 23 · Zai Lab Ltd: Material agreement
- Oct 21 · GSK gets FDA approval for hepatitis B drug that offers functional cure
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.